Expert Reaction to Study Looking at the Safety and Efficacy of GLP-1s in Children and Adolescents

GLP-1 Receptor Agonists Found to Improve Glycemic Control and Support Weight Loss in Youth with Type 2 Diabetes Amid Safety Concerns

A recent study has found that GLP-1 receptor agonists i […] The post GLP-1 Receptor Agonists Found to Improve Glycemic Control and Support Weight Loss in Youth with Type 2 Diabetes Amid Safety Concerns first appeared on GeneOnline News. The post GLP-1 Receptor Agonists Found to Improve Glycemic Control and Support Weight Loss in Youth with Type 2 Diabetes Amid Safety Concerns appeared first on GeneOnline News.

Study Highlights Benefits, Safety Considerations of GLP-1s in Children and Adolescents With T2D or Obesity

GLP-1 receptor agonists enhance glycemic control and weight management in youth with type 2 diabetes (T2D) and obesity, while safety concerns persist.

expert reaction to study looking at the safety and efficacy of GLP-1s in children and adolescents

A study published in JAMA Pediatrics looks at the safety of weight loss drugs in children and adolescents with obesity or type 2 diabetes.   Prof Naveed Sattar, Professor of Cardiometabolic Medicine/Honorary Consultant, University of Glasgow, said: “This paper is of only modest interest as although obesity levels are rising fastest in younger people, the present meta-analysis looks predominantly at trials with older GLP-1RAs known to give much l…